CUE CARD

Jakarta Urology Medical Update 2021:

Endourology Session

Sunday, June 6th, 2021

MC Opening (10.50-11.00)
Good afternoon, Ladies and Gentlemen, to all Professors, Urologist,
other medical specialists, residents, general practitioners, medical
students, and everyone who are joining us right now. Welcome to
Jakarta Urology Medical Update (JUMP) 2021 in conjunction with
Annual Scientific Meeting of Indonesian Continence Society Day 3
Allow me to Introduce myself, my name is Rio and I will be the master
of ceremony for today’s event.

• Klik next
4. Opening Ceremony (10.50-11.00)
• JUMP is an annual webinar, organized by Yayasan Pengembangan Urologi Jakarta.
• This Year, we introduce “Enhancing Surgery in Urology” as the main theme and
will be discussing various topics in Urology ranging from:
• Androurology
• Reconstructive Urology,
• Endourology,
• Onco-urology,
• Female and Functional Urology (in conjunction with PERKINA),
• Transplantation Urology,
• and Pediatric Urology in collaboration with APAPU (Asian Pacific Association of Pediatric
Urologist). All the topics will be covered within the 6 days of this webinar from May 23 RD
until June 25th 2021.
• (KLIK NEXT)
4. Opening Ceremony (10.50-11.00)
• We are delighted to inform you that there will be national and
international speakers in JUMP 2021.
• Before we begin our event today, let us take a moment to pray
according to our religion and beliefs. May we begin our prayer
• < pray >
• First of all, we, the committee of JUMP 2021, would like to thank all
the sponsors and media partners who have supported this event
• Klik next
4 & 5 Opening Sponsored Session by PT Mega
Lifesciences Indonesia: Role of Abiraterone Acetate in
Metastatic Prostate Cancer (11.00-12.00)
• Ladies and Gentleman, now we will proceed to our first agenda,
which is a sponsored session by PT Mega Lifesciences Indonesia
entitled Role of Abiraterone Acetate in Metastatic Prostate Cancer
• We would kindly welcome dr. Agus Rizal Hamid, (Urologist), PhD, to
lead and moderate the session.
• But before that, allow me to read dr Rizal’s CV
• (Baca CV)
 5. CV dr rizal
• dr. Rizal is a uro-oncology University
consultant in cipto2008
of Melbourne mangunkusumo national
Bachelor of Medical science
referral hospital faculty of•medicine univerasitas
Fakultas kedokteran, indonesia.
Universitas He Sarjana
Indonesia 2010
underwent his training in universitas indonesia kedokteran
and attained his PhD
• Fakultas kedokteran, Universitas Indonesia 2011 Dokter
in Radboud University – Nijmegen Medical center, nijmegen,
• Departemen Urologi, Fakultas Kedokteran, Universitas
netherland. Indonesia, Rumah Sakit Pusat Rujukan Nasional dr. Cipto
• He is also a member of many internationalMangunkusumo
committee such as SIU
Editorial board and innovator committee, national representative for
2019 Urologi
asian oncology society, editor in chief for medical journal of
indonesia, and also the main authors of many articles publishes in
scopus. To dr. Rizal the time is yours
 Agus Rizal A.H. Hamid, MD, PhD
Education
- Medical Doctor, Faculty of Medicine, Universitas Indonesia
- Urology Trainee, Faculty of Medicine, Universitas Indonesia
- PhD, Radboud University – Nijmegen Medical Center, Nijmegen,
Netherland

Notable participations & achievements

Medical Staff at - Editorial Board Member (2020 – present),
Department of Urology Société Internationale d’Urologie Journal.
- Innovator Committee (2020 – present),
Faculty of Medicine Société Internationale d’Urologie.
Universitas Indonesia – - National Representative (2019 – present),
Cipto Mangunkusumo Asian Oncology Society.
Hospital, Jakarta - - Editor-in-chief (2017 – present),
Indonesia Medical Journal of Indonesia.
- General Secretary (2017 - 2020),
Indonesian Urological Association.
- Main authors of several articles published in Scopus-indexed journals.
 14. Closing Sponsored Session PT Mega Lifesciences indonesia:
Role of Abiraterone Acetate in Metastatic Prostate Cancer

• MC: Thank you Professor Umbas, and Professor Chaidir for the
insightful lectures, and dr Agus Rizal for leading a productive
discussion during this session.
• We also would like to thank PT Mega Lifesciences indonesia as our
sponsor in this session
• Klik next
14. Closing Sponsored Session PT Mega Lifesciences
indonesia: Role of Abiraterone Acetate in Metastatic
Prostate Cancer
• Allow me to remind all of the participants. Please do take your time to kindly
visit our sponsor booths, as the certificate of participation in this webinar will
only be distributed to those who visit all of our sponsor booths.
• Additionally, those who have visited each booth 3 times or more will have the
opportunity to take part in the doorprize draw at the end of JUMP 2021 series.
• We would like to ask for your feedback via filling the form that can accessed by
scanning the following QR code or by opening the link
bit.ly/jump2021feedback.
• The next session Latest Evidence of BPH Medical Treatment sponsored by PT.
GSK. We will continue on 1 PM Jakarta Time. See you!
19. Opening Latest evidence of BPH medical
treatment GSK
(13.00-14.00)
• Hello good afternoon ladies and gentlemen. Welcome back to JUMP 2021.
Before we proceed allow me to remind all of the participants. Please do
take your time to kindly visit our sponsor booths and chat the sponsors, as
the certificate of participation in this webinar will only be distributed to
those who have visited and chatted with all of our sponsor booths.
• Our next session entitled Latest Evidence of BPH Medical Treatment will
begin shortly. This session is sponsored by PT. GSK
• This session will be moderated by Prof. Rainy Umbas, MD, PhD (onco-
urology consultant). Allow me to introduce Prof. Umbas by reading his CV
• (Baca CV)
 20. Prof. Umbas CV
• Prof. Rainy Umbas is a professor of Urology in Faculty of Medicine
University of Melbourne 2008 Bachelor of Medical science
Universitas Indonesia Dr. Cipto Mangunkusumo
• Fakultas National
kedokteran, Universitas referral
Indonesia 2010Hospital.
Sarjana
He underwent his training in universitas indonesia,kedokteran University hospital
Nijmegen Netherland, and• Fakultas
attained his PhD
kedokteran, from Indonesia
Universitas catholic2011
university
Dokter
• Departemen Urologi, Fakultas Kedokteran, Universitas
Nijmegen, Netherland. Indonesia, Rumah Sakit Pusat Rujukan Nasional dr. Cipto
• He has largely contributed to the development Mangunkusumo of uro-oncology and
urology in general in Indonesia. His notable organization participations are
president of indonesian society of uro-oncology, 2019 Urologi
president of indonesian
college of urology, president of urological association of asia, president of
the indonesian urological association, and NCCN Asia consensus panel
member of prostate, kidney, and bladder cancer. To prof umbas, the time is
yours
 Prof. Rainy Umbas, MD, PhD
Your photo Education
here - Medical Doctor from Universitas Indonesia 1975
- Urologist from Universitas Indonesia 1987
- Clinical and Research Fellow, University Hospital Nijmegen, Netherland 1990-1993
- PhD from Catholic University Nijmegen, Netherland 1994

Professor of Urology, Notable participations & achievements

Faculty of Medicine - Member of the Board of Professors, Faculty of Medicine Universitas Indonesia
Universitas Indonesia - President of Indonesian Society of Uro-Oncology
- President of Indonesian College of Urology
Dr. Cipto 2011-2017
Mangunkusumo - President of Urological Association of Asia
2006-2008
National General - President of the Indonesian Urological Association
Hospital 2000-2003
- NCCN Asia Consensus Panel member of Prostate, Kidney, and Bladder Cancer
- Honorary Member of European Association of Urology and Chinese Urological Association, and
Honorary Consultant for Asian School of Urology
- Speaker, The 32nd World Congress of Endourology and SWL 2014
- Invited Panel, Prostate Cancer Debate : Asia Pacific, Hong Kong
29. Closing Sponsor Session: Latest Evidence of BPH
Medical Treatment (GSK)
(13.00-14.00)
• C: Thank you dr Rizal and dr. Nur, for the enlighting lecture, and Prof.
Umbas for actively moderating the sessions. This is the end of 2nd
session of the JUMP 2021.
• We would also like to thank PT. GSK for supporting this session
• We will now move on to the third session of the day which will be:
Benign Prostatic Hyperplasia Endourology.
• <transisi>
• Klik next
31. Opening Sponsor Session: BPH Endourology
(14.00-15.55)

Ladies and gentlemen, we will now move on to the third session of the
day which will be: Benign Prostatic Hyperplasia Endourology.

Now I would like to re-introduce our moderator for this third session,
who is none other than dr. Agus Rizal PhD (Urologist). For participants
who have missed it, I would like to re-read dr rizal CV
Klik next
 32. CV dr. Rizal
University of Melbourne 2008 Bachelor of Medical science
dr. Rizal is a uro-oncology consultant in cipto
• Fakultas kedokteran, mangunkusumo
Universitas Indonesia 2010national
Sarjana
referral hospital faculty of medicine univerasitas kedokteran
indonesia. He underwent
• Fakultas kedokteran, Universitas Indonesia 2011 Dokter
his training in universitas indonesia andUrologi,
• Departemen attained
Fakultashis PhD inUniversitas
Kedokteran, Radboud
University – Nijmegen Medical Indonesia,
center, nijmegen,
Rumah Sakitnetherland.
Pusat Rujukan Nasional dr. Cipto
Mangunkusumo
He is also a member of many international committee such as SIU Editorial
2019 Urologi
board and innovator committee, national representative for asian oncology
sociaety, editor in chief for medical journal of indonesia, and also the main
authors of many articles publishes in scopus. To dr. Rizal the time is yours
 Agus Rizal A.H. Hamid, MD, PhD
Education
- Medical Doctor, Faculty of Medicine, Universitas Indonesia
- Urology Trainee, Faculty of Medicine, Universitas Indonesia
- PhD, Radboud University – Nijmegen Medical Center, Nijmegen,
Netherland

Notable participations & achievements

Medical Staff at - Editorial Board Member (2020 – present),
Department of Urology Société Internationale d’Urologie Journal.
- Innovator Committee (2020 – present),
Faculty of Medicine Société Internationale d’Urologie.
Universitas Indonesia – - National Representative (2019 – present),
Cipto Mangunkusumo Asian Oncology Society.
Hospital, Jakarta - - Editor-in-chief (2017 – present),
Indonesia Medical Journal of Indonesia.
- General Secretary (2017 - 2020),
Indonesian Urological Association.
- Main authors of several articles published in Scopus-indexed journals.
44 & 46. Ending BPH Endourology (14.00-
15.55)
• Thank you prof. sung yong cho, prof. seung june oh, and prof. george lee for sharing
your knowledge.
• And also dr. agus rizal for moderating the very fruitful discussion sesion.
• We would also like to thank PT. APL ZP Therapeutics member of Zuellig Pharma for
supporting one of the lecture
• After this we will move on to the last session today, entitled endoluminal urooncology.
• <transisi endoluminal>
• Ladies and gentlemen, we will begin the last session for today entitled endoluminal
urooncology, which will be moderated by Prof. Chaidir Arif Mochtar, PhD (Onco-
Urologist)
• I will introduce Prof Chaidir by reading his CV
47. CV Prof Chaidir
• Prof. Chaidir is a Professor of Urology in Faculty of Medicine
Universitas Indonesia Dr. Cipto Mangunkusumo National General
Hospital. He underent his training in the same university and
attained his PhD and finished his fellowship urologic laparoscopiy
from academic medical center, university of amsterdam.
• His most notable organization participations are: president of
indonesian continence society, president of indonesian urological
association, vice chairman of scientific committee, and urological
association of asia, and currently he is the director of urology training
program. To prof. Chaidir the time is yours
56. Closing Endoluminal
(17.40-17.45)
• Thank you Prof. Hyeoung Dong Yuk and dr. Rizal, for the insightful
lectures, and prof. Chaidir for masterfully moderating the lectures and
discussion. This is the end of the last session.
• On behalf of the committee, I would like to thank PT Mega
Lifesciences Indonesia, PT. GSK, and PT APL ZP Therapeutics,
member of zuellig pharma for as the sponsor of today’s webinar
• <KLIK NEXT>
58. Closing
(17.40-17.45)
• We would like to also thank our media partners AMSA dan Media Aesculapius,
and to all the speakers and moderators, and of course to all the participants who
have actively participated and contributed questions for our discussion sessions.
• Your presence and contribution has been very valuable for us. Before you go, we
would like to ask for your feedback via filling the form that can accessed by
scanning the following QR code or by opening the link bit.ly/jump2021feedback.
• Don’t forget to join us in our next session on June 12th, 2021 where we will be
exploring the topics concerning male and female incontinence. We look forward
to seeing you again. Last but not least, we’d like to remind you again to not
forget to pay our sponsor booths a visit in order to be eligible for the webinar
certificates. That’s all for today.
• I’m Rio, Thank you and goodnight! Stay safe everyone 